The Biomarker and Cardiac Function in Sepsis

The Biomarker and Associated Cardiac Function in the Patients With Sepsis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00800631

Enrollment

150

Registered

2008-12-02

Start date

2008-01-31

Completion date

2009-12-31

Last updated

2008-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

The development and severity of sepsis induced myocardial dysfunction can be monitored from the serum biomarker.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Sepsis patients with 2 of the followings when arrival ER and treated \> 6 hours: * BT \>38℃ or\<36℃ * HR \>90/min * RR \>20/min or PaCO2 \< 32 mmHg * WBC count \>12×109/L or \<4×109/L or immature form \>10％

Exclusion criteria

* Age \< 18 * Major trauma patients * Pregnancy * Willing to do not aggressive treatment

Countries

Taiwan

Contacts

Primary ContactChiungYuan Hsu, Mph

dtemer01@gmail.com886-2-23123456

Outcome results